Blood Eosinophilia is an on-Treatment Biomarker in Patients...

Pharmaceutics 2020 / 03 Vol. 12; Iss. 3

Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA

Moreira, Alvaro, Erdmann, Michael, Uslu, Ugur, Vass, Verona, Schuler, Gerold, Schuler-Thurner, Beatrice
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
Pharmaceutics
DOI:
10.3390/pharmaceutics12030210
Date:
March, 2020
File:
PDF, 894 KB
2020
Conversion to is in progress
Conversion to is failed